Rudolf Napieralski

705 total citations
21 papers, 517 citations indexed

About

Rudolf Napieralski is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rudolf Napieralski has authored 21 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Rudolf Napieralski's work include Epigenetics and DNA Methylation (10 papers), Cancer-related gene regulation (8 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Rudolf Napieralski is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Cancer-related gene regulation (8 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Rudolf Napieralski collaborates with scholars based in Germany, Netherlands and Denmark. Rudolf Napieralski's co-authors include Manfred Schmitt, Viktor Magdolen, Fred C.G.J. Sweep, John A. Foekens, Karin Mengele, Nadia Harbeck, Heinz Höfler, Ute Reuning, Gisela Keller and John W.M. Martens and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Rudolf Napieralski

21 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rudolf Napieralski Germany	13	303	186	138	114	66	21	517
Hala Nijmeh United States	11	177 0.6×	148 0.8×	115 0.8×	232 2.0×	45 0.7×	18	474
Oliver Stoß Germany	10	471 1.6×	138 0.7×	532 3.9×	334 2.9×	96 1.5×	16	1.0k
Ursula L. Harper United States	12	445 1.5×	120 0.6×	191 1.4×	234 2.1×	22 0.3×	14	723
Tatsunori Nishimura Japan	14	372 1.2×	245 1.3×	229 1.7×	73 0.6×	23 0.3×	20	609
Even Birkeland Norway	14	304 1.0×	175 0.9×	170 1.2×	98 0.9×	33 0.5×	28	668
Changbin Zhu China	14	298 1.0×	174 0.9×	179 1.3×	126 1.1×	43 0.7×	40	676
Chiara Ghimenti Italy	14	344 1.1×	166 0.9×	244 1.8×	49 0.4×	26 0.4×	29	621
Tiffany Juarez United States	8	147 0.5×	139 0.7×	150 1.1×	150 1.3×	18 0.3×	33	592
Kea Martin Switzerland	11	136 0.4×	48 0.3×	486 3.5×	100 0.9×	38 0.6×	15	763
Xueliang Fu China	16	286 0.9×	201 1.1×	265 1.9×	102 0.9×	56 0.8×	31	591

Countries citing papers authored by Rudolf Napieralski

Since Specialization

Citations

This map shows the geographic impact of Rudolf Napieralski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Napieralski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Napieralski more than expected).

Fields of papers citing papers by Rudolf Napieralski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Napieralski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Napieralski. The network helps show where Rudolf Napieralski may publish in the future.

Co-authorship network of co-authors of Rudolf Napieralski

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf Napieralski. A scholar is included among the top collaborators of Rudolf Napieralski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf Napieralski. Rudolf Napieralski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Napieralski, Rudolf, Gert Auer, Michaela Aubele, et al.. (2020). PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients. Breast Care. 16(5). 523–531. 4 indexed citations

Kotzsch, Matthias, Rudolf Napieralski, Dalila Darmoul, et al.. (2018). Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients’ prognosis. Journal of Cancer Research and Clinical Oncology. 144(6). 1109–1118. 4 indexed citations

Napieralski, Rudolf, Tibor Schuster, Michaela Aubele, et al.. (2018). PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients. International Journal of Oncology. 52(3). 755–767. 22 indexed citations

Napieralski, Rudolf, Aurelia Noske, Jürgen Lauber, et al.. (2018). Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer. Scientific Reports. 8(1). 16861–16861. 11 indexed citations

Perkins, Jonathan A., Rudolf Napieralski, Jonathan A. Perkins, et al.. (2018). therascreenPITX2 RGQ PCR assay for the assessment of PITX2 DNA-methylation status to investigate the role of the transcription factor PITX2 and the regulation of the Wnt/ß-catenin pathway in pathophysiological processes.. Protocol Exchange. 5 indexed citations

Aubele, Michaela, Manfred Schmitt, Rudolf Napieralski, et al.. (2017). The Predictive Value ofPITX2DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges. Disease Markers. 2017. 1–14. 21 indexed citations

Yang, Feng, Michaela Aubele, Axel Walch, et al.. (2017). Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer. Biological Chemistry. 398(10). 1151–1164. 19 indexed citations

Zhao, Shuo, Julia Dorn, Rudolf Napieralski, et al.. (2016). Plasmin(ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer. Biological Chemistry. 398(7). 765–773. 12 indexed citations

Dorn, Julia, Rudolf Napieralski, Enken Drecoll, et al.. (2016). Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer. Biological Chemistry. 397(12). 1265–1276. 29 indexed citations

10.

Arı, Ferda, Rudolf Napieralski, & Engı̇n Ulukaya. (2013). Changes in Gene Methylation Following Chemotherapy in Breast Cancer Cell Lines. Turkish Journal of Biochemistry. 38(2). 154–162. 1 indexed citations

11.

Arı, Ferda, Rudolf Napieralski, Engı̇n Ulukaya, et al.. (2011). Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline‐based chemotherapy and the demethylating agent decitabine. Cell Biochemistry and Function. 29(8). 651–659. 10 indexed citations

12.

Mengele, Karin, Rudolf Napieralski, Viktor Magdolen, et al.. (2010). Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Review of Molecular Diagnostics. 10(7). 947–962. 37 indexed citations

13.

Schmitt, Manfred, Karin Mengele, Rudolf Napieralski, et al.. (2010). Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Review of Molecular Diagnostics. 10(8). 1051–1067. 52 indexed citations

14.

Napieralski, Rudolf, Nils Brünner, Karin Mengele, & Manfred Schmitt. (2010). Emerging Biomarkers in Breast Cancer Care. Biomarkers in Medicine. 4(4). 505–522. 12 indexed citations

15.

Duffy, Michael J., Rudolf Napieralski, John W.M. Martens, et al.. (2009). Methylated genes as new cancer biomarkers. European Journal of Cancer. 45(3). 335–346. 85 indexed citations

16.

Schmitt, Manfred, Karin Mengele, Rudolf Napieralski, et al.. (2008). Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects. Breast Care. 3(2). 2–2. 21 indexed citations

17.

Napieralski, Rudolf, Katja Ott, Markus Kremer, et al.. (2007). Methylation of Tumor-Related Genes in Neoadjuvant-Treated Gastric Cancer: Relation to Therapy Response and Clinicopathologic and Molecular Features. Clinical Cancer Research. 13(17). 5095–5102. 31 indexed citations

18.

Baumann, Sabine, Gisela Keller, Rudolf Napieralski, et al.. (2006). The prognostic impact of O⁶‐Methylguanine‐DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma. International Journal of Cancer. 119(2). 264–268. 43 indexed citations

19.

Napieralski, Rudolf, Katja Ott, Markus Kremer, et al.. (2005). Combined GADD45A and Thymidine Phosphorylase Expression Levels Predict Response and Survival of Neoadjuvant-Treated Gastric Cancer Patients. Clinical Cancer Research. 11(8). 3025–3031. 61 indexed citations

20.

Napieralski, Rudolf, Bettina Kempkes, & Wolf Gutensohn. (2003). Evidence for Coordinated Induction and Repression of Ecto-5'-Nucleotidase (CD73) and the A2a Adenosine Receptor in a Human B Cell Line. Biological Chemistry. 384(3). 483–7. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact